114,613 Shares in BlackRock Capital Allocation Term Trust $BCAT Purchased by Perennial Investment Advisors LLC

Perennial Investment Advisors LLC acquired a new position in shares of BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 114,613 shares of the company’s stock, valued at approximately $1,826,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. lifted its position in shares of BlackRock Capital Allocation Term Trust by 341.7% during the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after purchasing an additional 1,582 shares in the last quarter. McIlrath & Eck LLC increased its holdings in shares of BlackRock Capital Allocation Term Trust by 169.6% in the first quarter. McIlrath & Eck LLC now owns 3,130 shares of the company’s stock valued at $44,000 after purchasing an additional 1,969 shares in the last quarter. Parallel Advisors LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust in the third quarter valued at approximately $47,000. Brown Brothers Harriman & Co. raised its position in BlackRock Capital Allocation Term Trust by 450.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock worth $81,000 after purchasing an additional 4,500 shares during the last quarter. Finally, Global Retirement Partners LLC bought a new position in BlackRock Capital Allocation Term Trust in the 2nd quarter worth approximately $115,000. Institutional investors own 36.12% of the company’s stock.

BlackRock Capital Allocation Term Trust Stock Down 0.4%

NYSE:BCAT opened at $15.81 on Thursday. The stock’s fifty day moving average price is $15.80 and its two-hundred day moving average price is $15.34. BlackRock Capital Allocation Term Trust has a 52-week low of $13.73 and a 52-week high of $16.20.

BlackRock Capital Allocation Term Trust Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be given a dividend of $0.2542 per share. The ex-dividend date is Tuesday, September 15th. This represents a c) dividend on an annualized basis and a dividend yield of 19.3%.

BlackRock Capital Allocation Term Trust Company Profile

(Free Report)

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.

Featured Stories

Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report).

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.